Biocon Limited
BIOCON
株式のランク
#3399
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
株価
$3.75
最終同期: 2026-10-19
時価総額
$5.13B
変化（1日）
-2.30%
変化（1年）
-9.49%
国
IN
取引 Biocon Limited (BIOCON)
カテゴリー
Healthcare
Biocon Limited（BIOCON）のP/B比率
October 2026 時点のP/B比率 TTM: 1.63
Biocon Limited の最新の財務報告および株価によると、現在のP/B比率（TTM）は 1.63 です。2024 年末時点でのP/B比率は 1.63 でした。
Biocon Limited の P/B 比率の履歴（2004 ～ 2026）
各年末時点のP/B比率
| 年 | P/B比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 1.63 | -13.16% |
| 2025 | 1.88 | 15.10% |
| 2024 | 1.63 | 18.32% |
| 2023 | 1.38 | -70.93% |
| 2022 | 4.74 | -25.52% |
| 2021 | 6.36 | 33.22% |
| 2020 | 4.78 | -20.52% |
| 2019 | 6.01 | -11.80% |
| 2018 | 6.82 | 48.33% |
| 2017 | 4.59 | 96.38% |
| 2016 | 2.34 | -18.48% |
| 2015 | 2.87 | 4.31% |
| 2014 | 2.75 | 31.60% |
| 2013 | 2.09 | 1.48% |
| 2012 | 2.06 | -37.93% |
| 2011 | 3.32 | 5.47% |
| 2010 | 3.15 | 72.13% |
| 2009 | 1.83 | -34.73% |
| 2008 | 2.80 | -36.29% |
| 2007 | 4.40 | -8.26% |
| 2006 | 4.79 | -7.95% |
| 2005 | 5.21 | -28.50% |
| 2004 | 7.28 | 0.00% |
同業他社のP/B比率
| 企業 | P/B比率 | P/B比率の差 | 国 |
|---|---|---|---|
| 6.251 | 282.91% |
US
|
|
| 13.2547 | 711.93% |
US
|
|
| 4.208 | 157.76% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | 278.71% |
NL
|
